The Circadia CX00 System (CX00)
Circadia Health, Inc. · Decision date Oct 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-15 for K262447, The Circadia CX00 System (CX00), submitted by Circadia Health, Inc. of El Segundo, California. The filing was received 07/16/2026 as a traditional 510(k), reviewed by the Cardiovascular panel, and not reviewed by a third party. The classification product code is DRT (cardiac monitor, including cardiotachometer and rate alarm) under regulation 870.2300, with BZQ listed as a subsequent product code. SESE means clearance to market, not PMA approval.
The public record does not describe the device's components, the specific change or comparison to a predicate device, or any performance data, and no summary statement appears in the public information. The TPLC listing shows earlier Circadia submissions K252676 and K261286 for the Circadia C300 System, but the record does not establish a predicate relationship between those clearances and CX00. No predetermined change control plan was authorized, and the device was not recorded as a combination product.
Clinical performance, indications for use, and labeling remain outside the supplied record and should be read from the original FDA documents rather than inferred from this clearance.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262447
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Circadia Health, Inc.
- Product code
- DRT
- Decision code
- SESE
- Decision date
- Oct 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm).
- Applicant
- Circadia Health, Inc.
- Product code
- DRT
- FDA device class
- 2
FDA decision timeline
K262447 received
Application receipt date recorded by FDA.
K262447 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DRT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
DistaSense(TM) (v1)K254058 | Life Detection Technologies | 510(k) clearance | Sep 25, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Circadia Health, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- El Segundo, CA
Sources and methodology
- Original FDA record: K262447
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records